RGGRX
Price
$17.13
Change
+$0.09 (+0.53%)
Updated
Apr 2 closing price
Net Assets
1.27B
RWIBX
Price
$62.90
Change
+$0.23 (+0.37%)
Updated
Apr 2 closing price
Net Assets
122.78B
Ad is loading...

RGGRX vs RWIBX

Header iconRGGRX vs RWIBX Comparison
Open Charts RGGRX vs RWIBXBanner chart's image
Victory RS Global R6
Price$17.13
Change+$0.09 (+0.53%)
VolumeN/A
Net Assets1.27B
American Funds Capital World Gr&Inc R2
Price$62.90
Change+$0.23 (+0.37%)
VolumeN/A
Net Assets122.78B
RGGRX vs RWIBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RGGRX vs. RWIBX commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGGRX is a StrongBuy and RWIBX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 123B vs. RGGRX (1.28B). RGGRX pays higher dividends than RWIBX: RGGRX (1.73) vs RWIBX (0.92). RGGRX was incepted earlier than RWIBX: RGGRX (6 years) vs RWIBX (23 years). RWIBX (1.51) is less costly to investors than RGGRX (0.72). RGGRX is a more actively managed with annual turnover of: 32.00 vs. RWIBX (27.00). RGGRX has a lower initial minimum investment than RWIBX: RGGRX (0) vs RWIBX (250). RGGRX annual gain was more profitable for investors over the last year : 6.48 vs. RWIBX (0.05). RGGRX return over 5 years is better than : 108.55 vs. RWIBX (64.01).
RGGRXRWIBXRGGRX / RWIBX
Total Expense Ratio0.551.5136%
Annual Report Gross Expense Ratio0.721.5148%
Fund Existence6 years23 years-
Gain YTD-4.3770.679-644%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.28B123B1%
Annual Yield % from dividends1.730.92188%
Returns for 1 year6.480.0514,265%
Returns for 3 years26.2210.51249%
Returns for 5 years108.5564.01170%
Returns for 10 yearsN/A38.23-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APVO1.380.38
+38.26%
Aptevo Therapeutics Inc
LCTX0.440.03
+6.37%
Lineage Cell Therapeutics
BIO245.525.52
+2.30%
Bio-Rad Laboratories IncClass A
HLLY2.57N/A
N/A
Holley
TR31.29-0.28
-0.89%
Tootsie Roll Industries Inc